Industrial - Machinery
Compare Stocks
5 / 10Stock Comparison
FELE vs NDSN vs GTLS vs ITW vs EMR
Revenue, margins, valuation, and 5-year total return — side by side.
Industrial - Machinery
Industrial - Machinery
Industrial - Machinery
Industrial - Machinery
FELE vs NDSN vs GTLS vs ITW vs EMR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Industrial - Machinery | Industrial - Machinery | Industrial - Machinery | Industrial - Machinery | Industrial - Machinery |
| Market Cap | $4.41B | $15.83B | $9.93B | $73.64B | $79.02B |
| Revenue (TTM) | $2.18B | $2.85B | $4.26B | $16.22B | $18.32B |
| Net Income (TTM) | $150M | $523M | $40M | $3.13B | $2.44B |
| Gross Margin | 35.2% | 55.2% | 32.6% | 44.1% | 52.7% |
| Operating Margin | 12.6% | 25.9% | 8.5% | 26.4% | 19.8% |
| Forward P/E | 21.8x | 24.9x | 16.4x | 22.7x | 21.7x |
| Total Debt | $280M | $2.09B | $3.74B | $8.97B | $13.76B |
| Cash & Equiv. | $100M | $108M | $366M | $851M | $1.54B |
FELE vs NDSN vs GTLS vs ITW vs EMR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Franklin Electric C… (FELE) | 100 | 197.0 | +97.0% |
| Nordson Corporation (NDSN) | 100 | 150.9 | +50.9% |
| Chart Industries, I… (GTLS) | 100 | 528.4 | +428.4% |
| Illinois Tool Works… (ITW) | 100 | 148.2 | +48.2% |
| Emerson Electric Co. (EMR) | 100 | 231.2 | +131.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: FELE vs NDSN vs GTLS vs ITW vs EMR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
FELE ranks third and is worth considering specifically for sleep-well-at-night.
- Lower volatility, beta 0.92, Low D/E 21.1%, current ratio 2.79x
- 5.4% revenue growth vs ITW's 0.9%
NDSN is the #2 pick in this set and the best alternative if growth exposure and valuation efficiency is your priority.
- Rev growth 3.8%, EPS growth 4.9%, 3Y rev CAGR 2.5%
- PEG 1.68 vs EMR's 4.81
- PEG 1.68 vs 4.81
- +51.8% vs ITW's +9.0%
GTLS is the clearest fit if your priority is long-term compounding.
- 7.7% 10Y total return vs NDSN's 298.2%
- Beta 0.56 vs EMR's 1.52
ITW carries the broadest edge in this set and is the clearest fit for income & stability and defensive.
- Dividend streak 12 yrs, beta 0.67, yield 2.4%
- Beta 0.67, yield 2.4%, current ratio 1.21x
- 19.3% margin vs GTLS's 0.9%
- 2.4% yield, 12-year raise streak, vs EMR's 1.5%
Among these 5 stocks, EMR doesn't own a clear edge in any measured category.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 5.4% revenue growth vs ITW's 0.9% | |
| Value | PEG 1.68 vs 4.81 | |
| Quality / Margins | 19.3% margin vs GTLS's 0.9% | |
| Stability / Safety | Beta 0.56 vs EMR's 1.52 | |
| Dividends | 2.4% yield, 12-year raise streak, vs EMR's 1.5% | |
| Momentum (1Y) | +51.8% vs ITW's +9.0% | |
| Efficiency (ROA) | 19.4% ROA vs GTLS's 0.4%, ROIC 29.0% vs 7.4% |
FELE vs NDSN vs GTLS vs ITW vs EMR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FELE vs NDSN vs GTLS vs ITW vs EMR — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NDSN leads in 1 of 6 categories
FELE leads 1 • EMR leads 1 • GTLS leads 1 • ITW leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
NDSN leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
EMR is the larger business by revenue, generating $18.3B annually — 8.4x FELE's $2.2B. ITW is the more profitable business, keeping 19.3% of every revenue dollar as net income compared to GTLS's 0.9%. On growth, FELE holds the edge at +9.9% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $2.2B | $2.8B | $4.3B | $16.2B | $18.3B |
| EBITDAEarnings before interest/tax | $322M | $851M | $644M | $4.6B | $4.7B |
| Net IncomeAfter-tax profit | $150M | $523M | $40M | $3.1B | $2.4B |
| Free Cash FlowCash after capex | $169M | $646M | $203M | $2.2B | $3.1B |
| Gross MarginGross profit ÷ Revenue | +35.2% | +55.2% | +32.6% | +44.1% | +52.7% |
| Operating MarginEBIT ÷ Revenue | +12.6% | +25.9% | +8.5% | +26.4% | +19.8% |
| Net MarginNet income ÷ Revenue | +6.9% | +18.4% | +0.9% | +19.3% | +13.3% |
| FCF MarginFCF ÷ Revenue | +7.8% | +22.7% | +4.8% | +13.6% | +17.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | +9.9% | +8.8% | -2.5% | +4.6% | +2.9% |
| EPS Growth (YoY)Latest quarter vs prior year | +13.4% | +44.2% | -36.1% | +11.8% | +28.2% |
Valuation Metrics
FELE leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 24.4x trailing earnings, ITW trades at a 96% valuation discount to GTLS's 628.5x P/E. Adjusting for growth (PEG ratio), NDSN offers better value at 2.26x vs EMR's 7.73x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $4.4B | $15.8B | $9.9B | $73.6B | $79.0B |
| Enterprise ValueMkt cap + debt − cash | $4.6B | $17.8B | $13.3B | $81.8B | $91.2B |
| Trailing P/EPrice ÷ TTM EPS | 30.75x | 33.39x | 628.45x | 24.36x | 34.92x |
| Forward P/EPrice ÷ next-FY EPS est. | 21.77x | 24.86x | 16.40x | 22.68x | 21.71x |
| PEG RatioP/E ÷ EPS growth rate | 3.53x | 2.26x | — | 2.53x | 7.73x |
| EV / EBITDAEnterprise value multiple | 13.82x | 20.66x | 14.33x | 17.74x | 18.07x |
| Price / SalesMarket cap ÷ Revenue | 2.07x | 5.67x | 2.33x | 4.59x | 4.39x |
| Price / BookPrice ÷ Book value/share | 3.41x | 5.31x | 2.79x | 23.15x | 3.94x |
| Price / FCFMarket cap ÷ FCF | 22.81x | 23.94x | 48.95x | 27.20x | 29.63x |
Profitability & Efficiency
Evenly matched — FELE and ITW each lead in 4 of 9 comparable metrics.
Profitability & Efficiency
ITW delivers a 97.4% return on equity — every $100 of shareholder capital generates $97 in annual profit, vs $1 for GTLS. FELE carries lower financial leverage with a 0.21x debt-to-equity ratio, signaling a more conservative balance sheet compared to ITW's 2.78x. On the Piotroski fundamental quality scale (0–9), EMR scores 7/9 vs ITW's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +11.4% | +16.8% | +1.2% | +97.4% | +12.1% |
| ROA (TTM)Return on assets | +7.6% | +10.2% | +0.4% | +19.4% | +5.8% |
| ROICReturn on invested capital | +14.7% | +10.5% | +7.4% | +29.0% | +8.2% |
| ROCEReturn on capital employed | +18.1% | +13.4% | +8.6% | +38.7% | +10.0% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 | 5 | 5 | 7 |
| Debt / EquityFinancial leverage | 0.21x | 0.69x | 1.11x | 2.78x | 0.68x |
| Net DebtTotal debt minus cash | $181M | $2.0B | $3.4B | $8.1B | $12.2B |
| Cash & Equiv.Liquid assets | $100M | $108M | $366M | $851M | $1.5B |
| Total DebtShort + long-term debt | $280M | $2.1B | $3.7B | $9.0B | $13.8B |
| Interest CoverageEBIT ÷ Interest expense | 24.75x | 7.44x | 1.08x | 14.53x | 6.46x |
Total Returns (Dividends Reinvested)
EMR leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in EMR five years ago would be worth $15,945 today (with dividends reinvested), compared to $11,886 for ITW. Over the past 12 months, NDSN leads with a +51.8% total return vs ITW's +9.0%. The 3-year compound annual growth rate (CAGR) favors EMR at 20.7% vs FELE's 3.2% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +3.6% | +18.2% | +0.6% | +3.1% | +4.3% |
| 1-Year ReturnPast 12 months | +17.7% | +51.8% | +37.6% | +9.0% | +30.4% |
| 3-Year ReturnCumulative with dividends | +10.0% | +34.5% | +62.7% | +19.5% | +75.9% |
| 5-Year ReturnCumulative with dividends | +20.3% | +42.4% | +29.5% | +18.9% | +59.5% |
| 10-Year ReturnCumulative with dividends | +231.4% | +298.2% | +772.5% | +189.4% | +206.6% |
| CAGR (3Y)Annualised 3-year return | +3.2% | +10.4% | +17.6% | +6.1% | +20.7% |
Risk & Volatility
GTLS leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
GTLS is the less volatile stock with a 0.56 beta — it tends to amplify market swings less than EMR's 1.52 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. GTLS currently trades 99.5% from its 52-week high vs ITW's 84.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.92x | 1.05x | 0.56x | 0.67x | 1.52x |
| 52-Week HighHighest price in past year | $111.53 | $305.28 | $208.51 | $303.16 | $165.15 |
| 52-Week LowLowest price in past year | $83.42 | $188.22 | $140.50 | $236.68 | $108.37 |
| % of 52W HighCurrent price vs 52-week peak | +89.6% | +93.1% | +99.5% | +84.3% | +85.4% |
| RSI (14)Momentum oscillator 0–100 | 54.8 | 59.3 | 51.2 | 45.3 | 61.3 |
| Avg Volume (50D)Average daily shares traded | 281K | 306K | 1.6M | 1.2M | 2.8M |
Analyst Outlook
Evenly matched — NDSN and ITW and EMR each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: FELE as "Hold", NDSN as "Buy", GTLS as "Buy", ITW as "Hold", EMR as "Buy". Consensus price targets imply 14.8% upside for EMR (target: $162) vs -6.5% for GTLS (target: $194). For income investors, ITW offers the higher dividend yield at 2.39% vs GTLS's 0.29%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $100.00 | $311.50 | $193.81 | $273.67 | $161.92 |
| # AnalystsCovering analysts | 11 | 20 | 37 | 28 | 41 |
| Dividend YieldAnnual dividend ÷ price | +1.1% | +1.1% | +0.3% | +2.4% | +1.5% |
| Dividend StreakConsecutive years of raises | 32 | 37 | 1 | 12 | 37 |
| Dividend / ShareAnnual DPS | $1.11 | $3.15 | $0.60 | $6.11 | $2.10 |
| Buyback YieldShare repurchases ÷ mkt cap | +3.8% | +1.9% | 0.0% | +2.0% | +1.6% |
NDSN leads in 1 of 6 categories (Income & Cash Flow). FELE leads in 1 (Valuation Metrics). 2 tied.
FELE vs NDSN vs GTLS vs ITW vs EMR: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is FELE or NDSN or GTLS or ITW or EMR a better buy right now?
For growth investors, Franklin Electric Co.
, Inc. (FELE) is the stronger pick with 5. 4% revenue growth year-over-year, versus 0. 9% for Illinois Tool Works Inc. (ITW). Illinois Tool Works Inc. (ITW) offers the better valuation at 24. 4x trailing P/E (22. 7x forward), making it the more compelling value choice. Analysts rate Nordson Corporation (NDSN) a "Buy" — based on 20 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — FELE or NDSN or GTLS or ITW or EMR?
On trailing P/E, Illinois Tool Works Inc.
(ITW) is the cheapest at 24. 4x versus Chart Industries, Inc. at 628. 5x. On forward P/E, Chart Industries, Inc. is actually cheaper at 16. 4x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Nordson Corporation wins at 1. 68x versus Emerson Electric Co. 's 4. 81x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — FELE or NDSN or GTLS or ITW or EMR?
Over the past 5 years, Emerson Electric Co.
(EMR) delivered a total return of +59. 5%, compared to +18. 9% for Illinois Tool Works Inc. (ITW). Over 10 years, the gap is even starker: GTLS returned +772. 5% versus ITW's +189. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — FELE or NDSN or GTLS or ITW or EMR?
By beta (market sensitivity over 5 years), Chart Industries, Inc.
(GTLS) is the lower-risk stock at 0. 56β versus Emerson Electric Co. 's 1. 52β — meaning EMR is approximately 173% more volatile than GTLS relative to the S&P 500. On balance sheet safety, Franklin Electric Co. , Inc. (FELE) carries a lower debt/equity ratio of 21% versus 3% for Illinois Tool Works Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — FELE or NDSN or GTLS or ITW or EMR?
By revenue growth (latest reported year), Franklin Electric Co.
, Inc. (FELE) is pulling ahead at 5. 4% versus 0. 9% for Illinois Tool Works Inc. (ITW). On earnings-per-share growth, the picture is similar: Emerson Electric Co. grew EPS 17. 8% year-over-year, compared to -92. 0% for Chart Industries, Inc.. Over a 3-year CAGR, GTLS leads at 38. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — FELE or NDSN or GTLS or ITW or EMR?
Illinois Tool Works Inc.
(ITW) is the more profitable company, earning 19. 1% net margin versus 1. 0% for Chart Industries, Inc. — meaning it keeps 19. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ITW leads at 26. 3% versus 12. 7% for FELE. At the gross margin level — before operating expenses — NDSN leads at 55. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is FELE or NDSN or GTLS or ITW or EMR more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Nordson Corporation (NDSN) is the more undervalued stock at a PEG of 1. 68x versus Emerson Electric Co. 's 4. 81x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Chart Industries, Inc. (GTLS) trades at 16. 4x forward P/E versus 24. 9x for Nordson Corporation — 8. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for EMR: 14. 8% to $161. 92.
08Which pays a better dividend — FELE or NDSN or GTLS or ITW or EMR?
All stocks in this comparison pay dividends.
Illinois Tool Works Inc. (ITW) offers the highest yield at 2. 4%, versus 0. 3% for Chart Industries, Inc. (GTLS).
09Is FELE or NDSN or GTLS or ITW or EMR better for a retirement portfolio?
For long-horizon retirement investors, Illinois Tool Works Inc.
(ITW) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 67), 2. 4% yield, +189. 4% 10Y return). Emerson Electric Co. (EMR) carries a higher beta of 1. 52 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ITW: +189. 4%, EMR: +206. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between FELE and NDSN and GTLS and ITW and EMR?
Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
FELE, NDSN, ITW, EMR pay a dividend while GTLS does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.